STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Recipharm and Isofol Medical AB, a Gothenburg-based pharmaceutical company developing novel products for unmet needs within oncology, are pleased to announce the formation of a collaboration to strengthen the development program of Isofol’s lead drug candidate Modufolin®.
Help employers find you! Check out all the jobs and post your resume.
